Develops the MagChipR point-of-care, lab-on-chip molecular diagnostic platform for rapid infectious disease testing
Develops the MagChipR point-of-care, lab-on-chip molecular diagnostic platform for rapid infectious disease testing. The in-development system combines ultra-fast PCR with giant magnetoresistance (GMR) biosensing to detect pathogens and antimicrobial resistance, with results in under 20 minutes depending on the assay.